Composition: Aceclofenac, Paracetamol & Serratiopeptidase Tablets

Dosage Form: Tablets

Packaging Type: ALU ALU

Packaging: 10*10

View Pdf




Description

VTV FORMULATIONS INDIA PVT LTD is here to offer the best range of products for your problems. Our company manufactures and supplies top-notch quality products that people most trust. VTV FORMULATIONS INDIA PVT LTD  manufactures Aceclofenac, Paracetamol & Serratiopeptidase Tablets,  therefore serve our customers with quality life and healthcare products. All the products made by us are GMP, WHO, and ISO-certified.

  1. Use of best raw materials for manufacturing 
  2. Adherence to quality control and quality assurance practices.
  3. Certified companies from ISO, GMP, and WHO.
  4. Air-tight and leak-proof packaging.

  5. ACECLOFENAC+PARACETAMOL+SERRATIOPEPTIDASE belongs to the class of drugs known as 'non-steroidal anti-inflammatory drugs' (NSAID). It is a fixed-dose combination composed of aceclofenac, paracetamol and serratiopeptidase.ACECLOFENAC+PARACETAMOL+SERRATIOPEPTIDASE is used in the reduction of pain and inflammation due to bone or soft tissue injury, resolution of postoperative inflammation, oedema (swollen tissue with fluid) and pain. Aceclofenac works by blocking the action of an enzyme known as cyclo-oxygenase (COX), which causes pain and swelling in the injured or damaged tissue. Paracetamol acts as a mild analgesic (pain reducer) and antipyretic (fever reducer), which enhances the pain relief action of aceclofenac. Serratiopeptidase is an enzyme which helps in the breakdown of a protein (fibrin) which is formed as a by-product of the clotted blood at the site of injury. It thus causes thinning of the fluids around the site of injury thereby making fluid drainage smoother in the swollen tissue.

  6. Side Effects 

    • Nausea
    • Stomach Pain
    • Loss of appetite
    • Diarrhoea
    • Stomach upset
    • Indigestion

Over Services

Subscribe

Stay ahead in healthcare with our curated pharmaceutical products Subscribe now for exclusive access to the latest innovations.

Copyright @2021.All rights reserved.